SCHEMBL932591

SCHEMBL932591

COc1ccc(Cl)cc1S(=O)(=O)N1CCN(C(C=O)Oc2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.58
ALDH1A1 P00352 4/20 0.58
KDM4E B2RXH2 1/20 0.58
POLB P06746 1/20 0.58
HPGD P15428 1/20 0.58
RAB9A P51151 1/20 0.58
MAPT P10636 2/20 0.52
LMNA P02545 2/20 0.52
TSHR P16473 1/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 2/20 0.52
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
ALOX12 P18054 1/20 0.49
CYP2C9 P11712 1/20 0.49
TP53 P04637 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
RECQL P46063 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932636 0.76 ALDH1A1 (0.50) ALDH1A1POLBLMNAKMT2AMEN1
SCHEMBL932795 0.75 LMNA (0.42) GAAKDM4EPOLBLMNAKMT2A
SCHEMBL1101965 0.75 ALDH1A1 (0.79) GAAALDH1A1KDM4EPOLBHPGD
SCHEMBL9950819 0.73 GAA (1.00) GAAALDH1A1KDM4EPOLBHPGD
SCHEMBL932174 0.73 MCOLN3 (0.50) GAAALDH1A1RAB9ALMNATSHR
SCHEMBL932971 0.73 MCOLN3 (0.58) GAAALDH1A1LMNATSHRKMT2A
SCHEMBL22834120 0.72 ALDH1A1 (0.79) GAAALDH1A1KDM4EPOLBHPGD
SCHEMBL788790 0.71 ALDH1A1 (0.77) GAAALDH1A1KDM4EPOLBHPGD
SCHEMBL931510 0.71 PKM (0.59) GAAALDH1A1KDM4EHPGDLMNA
SCHEMBL932415 0.71 LMNA (0.53) ALDH1A1KDM4ELMNATSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448581-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE Agios Pharmaceuticals, Inc. (US) 2012-05-09 EP disclosed
WO-2011002816-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2011-01-06 WO disclosed